Jeff Bezos Stock Portfolio: Top 10 Stock Picks

8. GRAIL, Inc. (NASDAQ:GRAL)

The interest of Jeff Bezos in GRAIL, Inc. (NASDAQ:GRAL) can be understood in context of the history of Bezos as a backer of disruptive, foundational healthcare platforms that use data computing. In January 2016, Bezos Expeditions joined Microsoft co-founder Bill Gates and sequencing giant Illumina to seed GRAIL’s initial $100 million launch round. The startup’s ultimate objective was to develop a holy grail diagnostic tool: a multi-cancer early detection liquid biopsy test. GRAIL’s flagship product, Galleri, utilizes advanced machine learning and next-generation sequencing to scan cell-free DNA in a single blood draw, detecting over 50 types of cancer before symptoms appear.

The bull case for GRAIL, Inc. (NASDAQ:GRAL) is anchored by its rapid commercial adoption curve and expanding insurance reimbursement coverage for its revolutionary Galleri multi-cancer diagnostic test. According to performance data, GRAIL has achieved significant volume growth, with hundreds of thousands of commercial tests delivered to health systems, employer programs, and concierge medical networks in Q1 2026. The company’s core operational moat lies in its vast, proprietary genomic dataset, which consistently improves the test’s positive predictive value through continuous machine learning refinement. Financially, as GRAIL scales its high-throughput laboratory infrastructure, unit economics are improving drastically, setting a clear path toward gross margin expansion.